Cargando…
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
The World Health Organization identifies tuberculosis (TB), caused by Mycobacterium tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist, they come with challenges such as a heavy pill regimen, prolonged treatment duration, and a strict schedule, leading to mul...
Autores principales: | Kumar, Mahesh, Virmani, Tarun, Kumar, Girish, Deshmukh, Rohitas, Sharma, Ashwani, Duarte, Sofia, Brandão, Pedro, Fonte, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609727/ https://www.ncbi.nlm.nih.gov/pubmed/37895831 http://dx.doi.org/10.3390/ph16101360 |
Ejemplares similares
-
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
por: Kumar, Girish, et al.
Publicado: (2023) -
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine
por: Sharma, Ashwani, et al.
Publicado: (2022) -
Nanocarrier-Mediated Topical Insulin Delivery for Wound Healing
por: Macedo, Ana S., et al.
Publicado: (2021) -
Antidepressive-Like Effect of Aegle marmelos Leaf Extract in Chronic Unpredictable Mild Stress-Induced Depression-Like Behaviour in Rats
por: Sharma, Ashwani, et al.
Publicado: (2022) -
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
por: Sharma, Ashwani, et al.
Publicado: (2022)